[go: up one dir, main page]

AR131735A1 - Agentes terapéuticos - Google Patents

Agentes terapéuticos

Info

Publication number
AR131735A1
AR131735A1 ARP240100220A ARP240100220A AR131735A1 AR 131735 A1 AR131735 A1 AR 131735A1 AR P240100220 A ARP240100220 A AR P240100220A AR P240100220 A ARP240100220 A AR P240100220A AR 131735 A1 AR131735 A1 AR 131735A1
Authority
AR
Argentina
Prior art keywords
therapeutic agents
disorders
diseases
role
useful
Prior art date
Application number
ARP240100220A
Other languages
English (en)
Inventor
Pierre Burssens
Jean Keyaerts
Marie Adolphine C Ledecq
Baptiste Manteau
Laurent Provins
Dominique Louis Swinnen
Original Assignee
UCB Biopharma SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB Biopharma SRL filed Critical UCB Biopharma SRL
Publication of AR131735A1 publication Critical patent/AR131735A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se refiere a un compuesto de fórmula (1) o una de sus sales farmacéuticamente aceptables, útil para el tratamiento de enfermedades y/o trastornos en los que el sistema Xc⁻ desempeña un papel.
ARP240100220A 2023-02-01 2024-01-31 Agentes terapéuticos AR131735A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP23154379 2023-02-01

Publications (1)

Publication Number Publication Date
AR131735A1 true AR131735A1 (es) 2025-04-30

Family

ID=85158430

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP240100220A AR131735A1 (es) 2023-02-01 2024-01-31 Agentes terapéuticos

Country Status (11)

Country Link
EP (1) EP4658647A1 (es)
KR (1) KR20250138803A (es)
CN (1) CN120615092A (es)
AR (1) AR131735A1 (es)
AU (1) AU2024215106A1 (es)
CL (1) CL2025002253A1 (es)
CO (1) CO2025011065A2 (es)
IL (1) IL322424A (es)
MX (1) MX2025008841A (es)
TW (1) TW202435891A (es)
WO (1) WO2024160722A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025117439A1 (en) * 2023-11-30 2025-06-05 Viva Star Biosciences (Us) Inc. Macrocycle compounds as inhibitors of nlrp3 activity and therapeutic uses thereof
WO2026022197A1 (en) 2024-07-25 2026-01-29 UCB Biopharma SRL Dibenzoazepinone based compounds as therapeutic agents for cancer treatment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150368213A1 (en) 2014-06-20 2015-12-24 The University of Montana, Missoula, MT Novel Inhibitors of System Xc-

Also Published As

Publication number Publication date
IL322424A (en) 2025-09-01
MX2025008841A (es) 2025-09-02
CL2025002253A1 (es) 2025-11-03
TW202435891A (zh) 2024-09-16
WO2024160722A1 (en) 2024-08-08
KR20250138803A (ko) 2025-09-22
AU2024215106A1 (en) 2025-09-18
EP4658647A1 (en) 2025-12-10
CN120615092A (zh) 2025-09-09
CO2025011065A2 (es) 2025-09-08

Similar Documents

Publication Publication Date Title
MX2021011606A (es) Compuestos dirigidos a prmt5.
AR131735A1 (es) Agentes terapéuticos
PE20220170A1 (es) Agentes moduladores del regulador de la conductancia transmembrana de la fibrosis quistica
DOP2021000254A (es) Compuestos de pirrolidina
CL2022003360A1 (es) Benzofurano, benzopirrol, benzotiofeno sustituidos y otros inhibidores del complemento estructuralmente relacionados (divisional de la solicitud 202002578)
CL2024001022A1 (es) Moléculas pequeñas para el tratamiento del cáncer
CL2021001396A1 (es) Derivados de panteteína y usos de los mismos
CO2021005070A2 (es) Inhibición de la proteasa 30 específica de la ubiquitina (usp30)
UY34974A (es) Piridazina 1,4 disustituida, análogos de la misma y métodos para tratar las enfermedades relacionadas con deficiencia del smn
UY27092A1 (es) Derivados del novedoso carbamato de quinuclidina y las composiciones medicinales que los contienen
AR128500A1 (es) Inhibidores de arn helicasa dhx9 y usos de los mismos
CL2020001020A1 (es) Derivados de bencimidazol y sus usos.
CL2019000768A1 (es) Compuestos de aza-indazol para usar en lesiones de tendones y/o ligamentos.
CO2025003263A2 (es) Inhibidores de kif18a y usos de estos
CO2021017202A2 (es) Compuestos tricíclicos
CL2023001339A1 (es) Un inhibidor de magl.
AR124449A1 (es) Inhibidores de sos1 y usos de los mismos
ECSP19084722A (es) Compuestos bicíclicos 5,6-fusionados y composiciones para el tratamiento de enfermedades parasitarias
CO2019002616A2 (es) Compuestos de indazol para usar en lesiones de tendones y/o ligamentos
CL2024002500A1 (es) Inhibidores de proteínas de unión a emopamilo y usos de estos
UY38133A (es) Nuevos inhibidores de cdk8/19
AR127561A1 (es) Compuestos para el tratamiento de trastornos dependientes de cinasas
CO2025001460A2 (es) Inhibidores de proteína de unión a emopamil y usos de estos
MX2024012198A (es) Compuestos y metodos para tratar canceres
AR133607A1 (es) Inhibidores de la proteína de unión al emopamilo y usos de estos